Severe COVID-19 Pneumonia in an Unvaccinated Female Treated With Remdesivir

Abstract

Though recent developments in the management of the coronavirus disease 2019 (COVID-19) pandemic have resulted in significant progress, its continued persistence demands continued consideration both of larger scale public health factors as well as individual patient management. We present a case that provides a broad perspective across several issues within both categories, of a morbidly obese 34-year-old unvaccinated female presenting with respiratory distress secondary to COVID-19 pneumonia, managed through remdesivir therapy. Though this case presents an example of successful management, it nonetheless emphasizes the demand for a renewed focus on vaccine hesitancy and obesity as public health issues, particularly within the context of the pandemic.

The Polk COVID-19 and Flu Response clinical trial: COVID-19 antibody positivity higher in Black EMS workers

“…COVID-19 is associated with severe respiratory illness, [1][2][3][4] ischemic strokes, subarachnoid hemorrhage 5 coagulopathic events, 6,7 threatened miscarriage, 8 and other serious pathologies. It is also associated with relatively benign infection.…”